导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.17% | 260/1050 |
| 近一周 | -2.99% | 497/1104 |
| 近一月 | -0.50% | 127/1102 |
| 近一季 | -4.64% | 392/1092 |
| 近半年 | 0.51% | 461/1070 |
| 近一年 | 27.48% | 176/1018 |
| 近两年 | 64.27% | 404/926 |
| 近三年 | 18.51% | 512/834 |
| 成立以来 | -13.74% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.10% 83/1070 |
17.00% 427/1101 |
- - |
- - |
| 2025 | 34.12% 412/1065 |
-1.70% 894/1014 |
5.81% 252/1038 |
22.05% 535/1050 |
5.65% 115/1065 |
| 2024 | -12.82% 815/1011 |
-3.95% 534/960 |
-1.92% 433/983 |
0.42% 951/991 |
-7.84% 816/1011 |
| 2023 | -21.69% 710/952 |
-1.47% 686/880 |
-6.83% 632/895 |
-5.92% 364/915 |
-9.33% 829/952 |
| 2022 | -23.69% 456/867 |
-18.85% 460/773 |
14.67% 128/806 |
-13.81% 505/845 |
-4.86% 645/867 |
| 2021 | -7.80% 458/740 |
0.98% 109/580 |
11.73% 314/659 |
-15.76% 623/704 |
-2.98% 542/740 |
| 2020 | - - |
- - |
- - |
- - |
19.88% 121/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 信澳蓝筹精选股票 VS. 东吴新产业精选股票A(580008) |